Stay updated on A(B)VD+Nivolumab in Frontline for HL Clinical Trial
Sign up to get notified when there's something new on the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page.

Latest updates to the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 in the page footer.SummaryDifference0.0%

- Check11 days agoChange DetectedPublications section wording updated to indicate PubMed-sourced items are automatically filled. The page now shows a Last Update Posted (Estimated) date and a Revision: v3.3.1.SummaryDifference0.3%

- Check18 days agoChange DetectedThe notice about government funding and NIH operating status has been removed. This does not affect the study details, eligibility criteria, or outcomes listed for NCT03033914.SummaryDifference0.3%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe two screenshots show no significant changes to core trial information or page structure. Any minor differences do not affect the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%

- Check69 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to A(B)VD+Nivolumab in Frontline for HL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page.